The University of Alabama at Birmingham (UAB) is a clinical research site located in Birmingham, Alabama, United States 35233.
Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.
The University of Alabama at Birmingham (UAB) has participated in 6 clinical trials with 1 currently active.
Therapeutic areas: Tibial Shaft Fractures, Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory.
Sponsors: University of Alabama at Birmingham, Caribou Biosciences, Inc., Gilead Sciences.
Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
The University of Alabama at Birmingham (UAB) has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The University of Alabama at Birmingham (UAB) has 6 clinical trials on record, with 1 currently active. Their work covers Tibial Shaft Fractures, Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory.
Yes — The University of Alabama at Birmingham (UAB) holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.